Università degli Studi di Perugia Dipartimento di MEDICINA Sezione

Università degli Studi di Perugia
Dipartimento di MEDICINA
Sezione Malattie Infettive
Coordinatore: Prof. Franco Baldelli
e-mail: [email protected]
Tel.: 075 578 4374
Segreteria:
e-mail: [email protected]
Tel.: 075 578 4375
Fax: 075 578 4346
Pubblicazioni selezionate (2011-2016)
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy.
Pirro, M; Mannarino, Mr; Francisci, D; Schiaroli, E; Bianconi, V; Bagaglia, F; Sahebkar, A; Mannarino, E; Baldelli, F. SCIENTIFIC
REPORTS. 2016; 6 () Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa.. Distrutti, E; Santucci, L; Cipriani, S;
Renga, B; Schiaroli, E; Ricci, P; Donini, A; Fiorucci, S.. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2015; 7 () 707Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected
patients. Lichtner, Miriam; Cicconi, Paola; Vita, Serena; Cozzi-Lepri, Alessandro; Galli, Massimo; Lo Caputo, Sergio; Saracino,
Annalisa; De Luca, Andrea; Moioli, Mariacristina; Maggiolo, Franco; Marchetti, Giulia; Vullo, Vincenzo; d'Arminio Monforte,
Antonella, Baldelli, Franco, Francisci, Daniela. THE JOURNAL OF INFECTIOUS DISEASES. 2015; 211 (2) 178Is "option B+" also being adopted in pregnant women in high-income countries? Temporal trends from a national study in Italy..
Floridia M;Guaraldi G;Ravizza M;Tibaldi C;Pinnetti C;Maccabruni A;Molinari A;Liuzzi G;Alberico S;Meloni A;Rizzi L;Dalzero
S;Tamburrini E;Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy; Francisci D. CLINICAL INFECTIOUS
DISEASES. 2015; 60 (1) 159Management of Meningitis Caused by Multi Drug-Resistant Acinetobacter Baumannii: Clinical, Microbiological and Pharmacokinetic
Results in a Patient Treated with Colistin Methanesulfonate. Schiaroli, Elisabetta; Maria Bruna Pasticci, ; Cassetta, Maria Iris; Fallani,
Stefania; Castrioto, Corrado; Pirro, Matteo; Novelli, Andrea; Angelis, Lucia Henrici De; D’Andrea, Marco Maria; Mezzatesta, Maria
Lina; Baldelli, Franco; Mencacci, Antonella. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES.
2015; 7 (1) 1Rate and Determinants of Residual Viremia in Multidrug-Experienced Patients Successfully Treated with Raltegravir-Based Regimens.
Baroncelli, S; Pirillo, Mf; Galluzzo, Cm; Antoni, Ad; Ladisa, N; Francisci, D; D'Ettorre, G; Segala, D; Vivarelli, A; Sozio, F[ 8 ]
...More. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2015; 31 (1) 71The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma. Renga, Barbara;
Francisci, Daniela; Carino, Adriana; Marchianò, Silvia; Cipriani, Sabrina; Chiara Monti, Maria; Del Sordo, Rachele; Schiaroli,
Elisabetta; Distrutti, Eleonora; Baldelli, Franco; Fiorucci, Stefano. SCIENTIFIC REPORTS. 2015; 5 () 15403[Trends in infective endocarditis in a medium-sized University Hospital in Italy: analysis of 232 cases].. Pallotto C;Martinelli
L;Baldelli F;Bucaneve G;Cecchini E;Malincarne L;Pasticci MB. LE INFEZIONI IN MEDICINA. 2014; 22 (2) 124A commercially available multiplex real-time PCR for detection of pathogens in cardiac valves from patients with infective
endocarditis.. Leli C;Moretti A;Pasticci MB;Cenci E;Bistoni F;Mencacci A. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS
DISEASE. 2014; 79 (1) 98Acute appendicitis due to Cytomegalovirus in an apparently immunocompetent patient: a case report. Pasticci MB; Corsi S; Spigarelli
F; Correnti S.; Francisci D; Castronari r; Baldin P; Prosperini A; Baldelli F; Cenci e; Sensini A; morelli o.. JOURNAL OF MEDICAL
CASE REPORTS. 2014; 8 (1) 92Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with
ribavirin.. Santantonio T;Fasano M;Sagnelli E;Tundo P;Babudieri S;Fabris P;Toti M;Di Perri G;Marino N;Pizzigallo E;Angarano
G;Acute Hepatitis C Study Group; Francisci D. HEPATOLOGY. 2014; 59 (6) 2101Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational
national study.. Floridia M, Ravizza M, Masuelli G, Giacomet V, Martinelli P, Degli Antoni A, Spinillo A, Fiscon M, Francisci D,
Liuzzi G, Pinnetti C, Marconi AM, Tamburrini E; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy. JOURNAL
OF ANTIMICROBIAL CHEMOTHERAPY. 2014; 69 (5) 1377Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to
Italian patients in Italy: a retrospective multicentre study,2000-2010.. Sulis G; El Hamad I; Fabiani M; Rusconi S; Maggiolo F;
Guaraldi G; Bozzi G; Bernardini C; Lichtner M; Stetarelli C; Carenzi L; Francisci D; Saracino A; Castelli F.. INFECTION. 2014; 42
(5) 859Development of a definition for rapid progression (RP) of renal function in HIV-positive persons:the D:A:D study. Kamara DA; Ryom
L; Ross M; Kirk O; Reiss P; Morlat P; Moranne O; Fux CA; Mocroft A; Sabin C; Lundgren JD; Smith CJ; D:A:D study group;
Francisci D.. BMC NEPHROLOGY. 2014; 15 (51) Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting.. d'Arminio
Monforte A;Gianotti N;Cozzi-Lepri A;Pinnetti C;Andreoni M;di Perri G;Galli M;Poli A;Costantini A;Orofino G;Maggiolo
F;Mazzarello G;Celesia BM;Luciani F;Lazzarin A;Sighinolfi L;Rizzardini G;Bonfanti P;Perno CF;Antinori A;ICONA Foundation
Cohort; Baldelli F. ANTIVIRAL THERAPY. 2014; 19 (3) 319Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or
experiencing episodes of virologiccal failure. Rozera G; Abbate I; Giombini E; Castagna A; De luca a; Ceccherini-Silberstein F; CozziLepri A; Cassola G; Torti C; d?Arminio Monforte A; Ippolito G; ICONA foundation group; D.Francisci; Baldelli F. JOURNAL OF
ANTIMICROBIAL CHEMOTHERAPY. 2014; 69 (11) 3085Highly Active Antiretroviral Therapy-related Mechanisms of Endothelial and Platelets Function Alterations. Paolo Gresele; Emanuela
Falcinelli; Stefania Momi; Daniela Francisci; Franco Baldelli. REVIEWS IN CARDIOVASCULAR MEDICINE. 2014; 15 (1) S91
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona
Foundation study.. Marchetti G;Cozzi-Lepri A;Tincati C;Calcagno A;Ceccherini-Silberstein F;De Luca A;Antinori A;Castagna
A;Puoti M;Monforte Ad;Icona Foundation Study Group; Baldelli F. BMC INFECTIOUS DISEASES. 2014; 14 (79) In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors.. Renga B; Mencarelli A; Cipriani S;
D'Amore C; D Francisci; Santucci L; Baldelli F; Distrutti E; Fiorucci S.. EUROPEAN JOURNAL OF PHARMACOLOGY. 2014; 15
(723) 194Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and
general population CVD risk equations.. Petoumenos K;Reiss P;Ryom L;Rickenbach M;Sabin CA;El-Sadr W;d'Arminio Monforte
A;Phillips AN;De Wit S;Kirk O;Dabis F;Pradier C;Lundgren JD;Law MG;D:A:D study group; Francisci D; Baldelli F. HIV
MEDICINE. 2014; 15 (10) 595Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing
successful first-line antiretroviral therapy. G. Meini;B. Rossetti;C. Bianco;F. Ceccherini-Silberstein;S. D. Giambenedetto;L.
Sighinolfi;L. Monno;A. Castagna;G. Rozera;A. D. Monforte;M. Zazzi;A. D. Luca; D. Francisci; F. Baldelli. JOURNAL OF
ANTIMICROBIAL CHEMOTHERAPY. 2014; 69 (3) 735Potential anti-inflammatory effects of maraviroc in HIV-positive patients: a pilot study of inflammation, endothelial dysfunction, and
coagulation markers.. Francisci D; Falcinelli E; Baroncelli s; Petito E; Cecchini E; Weimer LE; Floridia M; Gresele P; Baldelli F..
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2014; 46 (6) 466Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian study on
endocarditis (SEI).. Rizzi M;Ravasio V;Carobbio A;Mattucci I;Crapis M;Stellini R;Pasticci MB;Chinello P;Falcone M;Grossi
P;Barbaro F;Pan A;Viale P;Durante-Mangoni E. BMC INFECTIOUS DISEASES. 2014; 14 (1) 230Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group,
years 1997-2013.. d'Arminio Monforte A;Galli L;Lo Caputo S;Lichtner M;Pinnetti C;Bobbio N;Francisci D;Costantini A;Cingolani
A;Castelli F;Girardi E;Castagna A;ICONA Foundation Study Group; Baldelli F. JOURNAL OF ACQUIRED IMMUNE
DEFICIENCY SYNDROMES. 2014; 67 (3) 258Prevalence and predictors of malignancies in a polycentric cohort of HIV patients from Italy.. Mazzotta E;Tontodonati M;Gabrielli
C;Mazzocato S;Mazzetti M;Falasca K;Cenderello G;Vecchiet J;Barchiesi F;Francisci D;Parruti G. JOURNAL OF THE
INTERNATIONAL AIDS SOCIETY. 2014; 17 () 105Rate and Determinans of residual viremia in multidrug-experienced patients successfully trated with raltegravir-based regimens..
Baroncelli S; Pirillo MF; Galluzzo CM; Degli Antoni A; Ladisa N; Francisci D; d'Ettorre G; Segala d; Vivarelli A; Sozio F; Cirioni O;
Weimer LE; Fragola V; Parruti G; Floridia M.. HIV CLINICAL TRIALS. 2014; 31 (1) 71Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in Italy.. Floridia,
M; Pinnetti, C; Ravizza, M; Frisina, V; Cetin, I; Fiscon, M; Francisci, D; Degli Antoni, A; Guaraldi, G; Vimercati, A[ 10. HIV
CLINICAL TRIALS. 2014; 15 (3) 104Relationship between health-related quality of life measures and high HIV viral load in HIV-infected triple-class-experienced patients..
Bucciardini R; Pugliese K; Weimer L; Digregorio M; Fragola V; Mancini M; Maroccia Z; Ladisa N; Francisci D; Bellagamba R; Degli
antoni A; Guaraldi G; Cirioni O; Ortu F; Parruti G; Mannazzu M; Libertone R; Donnini S; Floridia M.. HIV CLINICAL TRIALS.
2014; 15 (4) 176Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral
treatment: A phase I safety and immunogenicity study.. Iaria ML; Fiorentini S; Focà E; Zicari S; Giagulli C; Caccuri F; Francisci D; Di
Perri G; Castelli F; Baldelli F; Caruso A.. VACCINE. 2014; 32 (9) 1072Targeting FXR in cholestasis: hype or hope.. Fiorucci S; Distrutti E; Ricci P; Giuliano V; Donini A; Baldelli F.. EXPERT OPINION
ON THERAPEUTIC TARGETS. 2014; 18 (12) 1449The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan2. Renga B; Francisci D; Schiaroli E; Carino A; Cipriani S; D'Amore C; Sidoni A; Del Sordo R; Ferri I; Lucattelli M; Lunghi B;
Baldelli F; Fiorucci S.. PLOS ONE. 2014; 9 (4) e94798Tolerability and efficacy of long-term treatment with daptomycin, ceftazidime and colistin in a patient with a polymicrobial, multidrugresistant prosthetic joint reinfection: a case report.. Pasticci M.B.;Di Filippo P;Pasqualini L;Mencacci A;Pallotto C;Malincarne
L;Baldelli F. JOURNAL OF MEDICAL CASE REPORTS. 2014; 8 () Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.. Smith CJ;Ryom
L;Weber R;Morlat P;Pradier C;Reiss P;Kowalska JD;de Wit S;Law M;el Sadr W;Kirk O;Friis-Moller N;Monforte Ad;Phillips
AN;Sabin CA;Lundgren JD;D:A:D Study Group; Baldelli F. THE LANCET. 2014; 384 (9939) 241[Trend of syphilis among patients at the Infectious Diseases Clinic of Perugia, Italy: a six-year observational retrospective study]..
Malincarne L;Angeli G;Francisci D;Baldelli F;Pasticci MB. LE INFEZIONI IN MEDICINA. 2013; 21 (1) 14Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of
HIV/HBV co-infected patients in Italy.. Antonucci G;Mazzotta F;Angeletti C;Girardi E;Puoti M;De Stefano G;Grossi P;Petrosillo
N;Pagano G;Cassola G;Orani A;Sagnelli C;Armignacco O;Sagnelli E;Coorte Epatiti B SIMIT/COESI-B (HIV) Group; Baldelli F..
BMC RESEARCH NOTES. 2013; 6 (153) Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs
and aspirin in mice.. Cipriani S; Mencarelli A; Bruno A; Renga B; Distrutti E; Santucci L; Baldelli F; Fiorucci S.. BRITISH
JOURNAL OF PHARMACOLOGY. 2013; 168 (1) 225Anal Cancer Screening for Diagnosis and Treatment of Anal Squamous Intraepithelial Lesions in HIV-positive MSM patients. Mercuri
A; Sfara C; Cavazzoni E; Del Sordo R; Marino E; Graziosi L; Baldelli F; Francisci D. JOURNAL OF AIDS & CLINICAL
RESEARCH. 2013; 5 (1) Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function:
the D:A:D study.. Ryom L;Mocroft A;Kirk O;Worm SW;Kamara DA;Reiss P;Ross M;Fux CA;Morlat P;Moranne O;Smith
C;Lundgren JD;D:A:D Study Group; Francisci D; Baldelli F. THE JOURNAL OF INFECTIOUS DISEASES. 2013; 207 (9) 1359Associations between immune depression and cardiovascular events in HIV infection.. Sabin CA;Ryom L;De Wit S;Mocroft A;Phillips
AN;Worm SW;Weber R;D'Arminio Monforte A;Reiss P;Kamara D;El-Sadr W;Pradier C;Dabis F;Law M;Lundgren J;D:A:D Study
Group; Baldelli F. AIDS. 2013; 27 (17) 2735Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.. Floridia M, Mastroiacovo P, Tamburrini
E, Tibaldi C, Todros T, Crepaldi A, Sansone M, Fiscon M, Liuzzi G, Guerra B, Vimercati A, Vichi F, Vicini I, Pinnetti C, Marconi
2
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
AM, Ravizza M; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy, Francisci D.. BJOG-AN INTERNATIONAL
JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2013; 120 (12) 1466Body Mass Index and Weight Gain in Pregnant Women with HIV: a National Study in Italy. Floridia M, Ravizza M, Masuelli g,
Dalzero S, Pinnetti C, Cetin I, Meloni A, Spinillo A, Rubino E, Francisci D, Tamburrini E; for the Italian Group on Surveillance on
Antiretroviral Treatment in Pregnancy. CLINICAL INFECTIOUS DISEASES. 2013; 56 (8) 1190CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination.. Mencarelli A; Graziosi L; Renga B;
Cipriani S; D'Amore C; Francisci D; Bruno A; Baldelli F; Donini A; Fiorucci S.. TRANSLATIONAL ONCOLOGY. 2013; 6 (6) 784Cerebrospinal fluid penetration of tigecycline.. Pallotto C;Fiorio M;D'Avolio A;Sgrelli A;Baldelli F;Di Perri G;De Socio GV.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2013; 46 (1) 69Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive
persons.. Rotger M;Glass TR;Junier T;Lundgren J;Neaton JD;Poloni ES;van 't Wout AB;Lubomirov R;Colombo S;Martinez R;Rauch
A;Günthard HF;Neuhaus J;Wentworth D;van Manen D;Gras LA;Schuitemaker H;Albini L;Torti C;Jacobson LP;Li X;Kingsley
LA;Carli F;Guaraldi G;Ford ES;Sereti I;Hadigan C;Martinez E;Arnedo M;Egaña-Gorroño L;Gatell JM;Law M;Bendall C;Petoumenos
K;Rockstroh J;Wasmuth JC;Kabamba K;Delforge M;De Wit S;Berger F;Mauss S;de Paz Sierra M;Losso M;Belloso WH;Leyes
M;Campins A;Mondi A;De Luca A;Bernardino I;Barriuso-Iglesias M;Torrecilla-Rodriguez A;Gonzalez-Garcia J;Arribas JR;Fanti
I;Gel S;Puig J;Negredo E;Gutierrez M;Domingo P;Fischer J;Fätkenheuer G;Alonso-Villaverde C;Macken A;Woo J;McGinty T;Mallon
P;Mangili A;Skinner S;Wanke CA;Reiss P;Weber R;Bucher HC;Fellay J;Telenti A;Tarr PE;MAGNIFICENT
Consortium;INSIGHT;Swiss HIV Cohort Study; Baldelli F.. CLINICAL INFECTIOUS DISEASES. 2013; 57 (1) 112Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe. De Luca A; Dunn D;
Zazzi m; Camacho r; Torti C; Fanti I; Kaiser R; Sonnerborg A; codoner FM; Van Laethem K; Vandamme AM; Bansi L; Ghisetti V;
van de Vijver DA; Asboe D; Prosperi MC; Di Giambenedetto S. SEHERE collaboration in Chain; Francisci D.. THE JOURNAL OF
INFECTIOUS DISEASES. 2013; 207 (8) 1216Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside
reverse transcriptase inhibitors with and without thymidine analogues.. Santoro M; Sabin C; Forbici F; Bansi l; Dunn D; Fearnhill E;
Boumis E; Nicastri E; Antinori A; Palamara g; Callegaro A; Francisci D; Zoncada A; Maggiolo F; Zazzi M; Perno C; CeccheriniSilberstein F; Mussini C.. HIV MEDICINE. 2013; 14 (9) 571Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir,efavirenz or
lopinavir/ritonavir in the Italian ARCA cohort. Di Biagio A, Prinapori R, Giannarelli D, Maggiolo f, Di Giambenedetto S, Borghi V,
Penco G, Cicconi P, Francisci D, Sterrantino G, Zoncada A, Monno L, Capetti A, Giacometti A; ARCA Collaborative Group.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2013; 68 (1) 200Early aetiological agent identification of osteomyelitis with the Light Cycler Septifast Test from peripheral blood.. M.B.Pasticci;
G.Rinonapoli; C.Leli; A.Mencacci. BMJ CASE REPORT. 2013; 2013 () 1Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in
mice.. Cipriani S; D Francisci; Mencarelli A; B Renga; Schiaroli E; D'Amore C; Baldelli F; Fiorucci S.. CIRCULATION. 2013; 127
(21) 2114FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity.. Mencarelli A; Cipriani
S; Renga B; D'Amore C; Palladino G; Distrutti E;Baldelli F; Fiorucci S.. NMCD. NUTRITION METABOLISM AND
CARDIOVASCULAR DISEASES. 2013; 23 (2) 94Hepatitis B in immunosuppressed cancer patients:pathogenesis, incidence and prophylaxis. Mandalà M; Fagiuoli S; Francisci D; Bruno
R; Merelli B; Pasulo L; Tondini C; Labianca R; Roila F.. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2013; 87 (1) 12In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients.. Falcinelli E; Francisci D; Belfiori B;
Petito E; Guglielmini G; Malincarne L; Mezzasoma A; Sebastiano M; Conti V; Giannini S; Bonora S; Baldelli F; Gresele P..
THROMBOSIS AND HAEMOSTASIS. 2013; 110 (2) 349Inconsistent condom use among HIV-positive women in the "Treatment as Prevention Era": data from the Italian DIDI study. Cicconi
P, Monforte Ad, Castagna A, Quirino T, Alessandrini A, Gargiulo M, Francisci D, Anzalone E, Liuzzi G, Pierro P, Ammassari A;
DIDI Study Group. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2013; 16 () 18591Induced first abortion rates before and after HIV diagnosis:results of an Italian self-administered questionnaire survey carried out in
585 women living with HIV.. Ammassari A; Cicconi P; Ladisa N; Di Sora F; Bini T; Trotta MP; D'Ettorre G; Cattelan AM; Vichi f;
D'Arminio Monforte A. ; DIDI Study Group; Francisci D.. HIV MEDICINE. 2013; 14 (1) 31Interindividual and intra-individual variabilities of Darunavir and Ritonavir plasma trough concentrations in multidrug experienced
HIV patients receiving salvage regimens. Baroncelli S; Villani P; Galluzzo CM; Cavalli A; Volpe A; Francisci D; Vivarelli A; Sozio F;
Tedeschi S; Cirioni o; Sighinolfi L; Cusato M; Pirillo MF; Weimer LE; Fragola v; Parruti G; Regazzi M; Floridia M.. THERAPEUTIC
DRUG MONITORING. 2013; 35 (6) 785Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomised clinical
trial.. Rusconi S; Vitiello P; Adorni f; Colella e; Focà E; Capetti A; Meraviglia P; Abeli C; Bonora S; D'annunzio M; Di Biagio A; Di
Pietro M; Butini l; Orofino G; Colafigli M; d'Ettorre G; Francisci D; Parruti G; Soria A; Buonimini AR; Tommasi C; Mosti s; Bai f; Di
Nardo Stuppino S; Morosi M; Montano M; Tau P; Merlini E; Marchetti g.. PLOS ONE. 2013; 8 (11) e80157No evidence of autoimmune disorders in antiretroviral-experienced HIV-1-infected individuals after long-term treatment with
raltegravir.. Baroncelli S; Mezzaroma I; Fantauzzi A; Galluzzo CM; Antoni AD; Vullo V; Francisci D; Ladisa N; Vivarelli A; Cirioni
O; Sighinolfi l; Weimer LE; Fragola V; Fidanza R; Cara A; Palmisano L.. ANTIVIRAL THERAPY. 2013; 18 (3) 321Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.. Worm SW;Bower M;Reiss
P;Bonnet F;Law M;Fätkenheuer G;d'Arminio Monforte A;Abrams DI;Grulich A;Fontas E;Kirk O;Furrer H;De Wit S;Phillips
A;Lundgren JD;Sabin CA;D:A:D Study Group; Baldelli F.. BMC RESEARCH NOTES. 2013; 13 (471) Pregnancy outcomes in HIV-infected women of advanced maternal age.. Liuzzi G, Pinnetti C, Floridia M, Tamburrini e, Masuelli G,
Dalzero s, Sansone m, Giacomet V, Degli Antoni AM, Guaraldi G, Meloni A, Maccabruni A, Alberico S, Portelli V, Ravizza M;Italian
Group On Surveillance on Antiretroviral Treatment in Pregnancy, Francisci D.. HIV CLINICAL TRIALS. 2013; 14 (3) 110Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection.. Weimer
LE, Fragola v, Floridia M, Guaraldi g, Ladisa N, Francisci D, Bellagamba R, Degli Antoni A, Parruti g, Giacometti A, Manconi PE,
Vivarelli A, D'Ettorre G, Mura MS, Cicalini S, Preziosi R, Sighinolfi L, Verrucchi G, Libertone R, Tavio M, Sarmati L, Bucciardini R;
on behalf of the ISS-NIA Study Group, Baldelli F. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2013; 68 (1) 1933
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination
antiretroviral treatment.. Lapadula G;Cozzi-Lepri A;Marchetti G;Antinori A;Chiodera A;Nicastri E;Parruti G;Galli M;Gori A;Monforte
Ad;ICONA Foundation Study; Baldelli F. AIDS. 2013; 27 (5) 769Stroke in a Patient with Tuberculous Meningitis and HIV Infection.. Pasticci M.B.;Paciaroni M;Floridi P;Cecchini E;Baldelli F.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES. 2013; 5 (1) e2013017Stroke in patients with tuberculous meningitis in a low TB endemic country: an increasing medical emergency?. Pasticci MB;Paciaroni
M;Floridi P;Malincarne L;Scavizzi M;Baldelli F. NEW MICROBIOLOGICA. 2013; 36 (2) 193Syphilis as a diagnosis of liver abnormalities in HIV.. Malincarne L;Pasticci MB;Angeli G;Baldelli F;De Socio GV.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2013; 45 (9) 703TB meningitis in HIV-positive patients in Europe and Argentina: clinical outcome and factors associated with mortality.. Efsen
AM;Panteleev AM;Grint D;Podlekareva DN;Vassilenko A;Rakhmanova A;Zeltina I;Losso MH;Miller RF;Girardi E;Caylá J;Post
FA;Miro JM;Bruyand M;Furrer H;Obel N;Lundgren JD;Mocroft A;Kirk O;HIV/TB Study Group; Baldelli F; Francisci D. BIOMED
RESEARCH INTERNATIONAL. 2013; 2013 () 373601The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation. Renga B; Mencarelli A;
Cipriani S; D'Amore C; Carino A; Bruno A; Francisci D; Zampella A; Distrutti E; Fiorucci S.. PLOS ONE. 2013; 8 (1) e54472A giant pancreatic pseudocyst in a patient with HIV infection.. De Socio GV;Vispi M;Fischer MJ;Baldelli F. JOURNAL OF THE
INTERNATIONAL ASSOCIATION OF PHYSICIANS IN AIDS CARE. 2012; 11 (4) 227Achromobacter denitrificans renal abscess.. Sgrelli A; Mencacci A; Fiorio M; Orlandi C; Baldelli F; De Socio GV.. NEW
MICROBIOLOGICA. 2012; 35/2012 () 245An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in
Italy.. Iorio AM.; Camilloni B.; Basileo M.; Monaldi L.; Lepri E.; Neri M.; Marcucci M.; Baldelli F.. JOURNAL OF CLINICAL
MEDICINE RESEARCH. 2012; () Changing Italian nosocomial-community trendsand heteroresistance in Staphylococcus aureusfrom bacteremia and endocarditis. F.
Campanile; D. Bongiorno; M. Falcone; F. Vailati; M. B. Pasticci; M. Perez; A. Raglio; F. Rumpianesi; C. Scuderi; F. Suter; M.
Venditti; C. Venturelli; V. Ravasio; M. Codeluppi; S. Stefani. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY &
INFECTIOUS DISEASES. 2012; 31 (5) 739Diagnosis of infective endocarditis: comparison of the LightCycler SeptiFast (Roche Diagnostics) real-time PCR with blood culture..
Mencacci A; Leli C; Montagna P; Cardaccia A; Meucci M; Bietolini C; Cenci E; Pasticci MB; Bistoni F.. JOURNAL OF MEDICAL
MICROBIOLOGY. 2012; 61(Pt 6) (6) 881Endothelial and platelet function alterations in HIV-infected patients.. Gresele P.; Falcinelli E.; Sebastiano M.; Baldelli F..
THROMBOSIS RESEARCH. 2012; 3 (129) 301Epidemiology and new developments in the diagnosis of prosthetic joint infection.. Corvec S;Portillo M.E.;Pasticci M.B.;Borens
O;Trampuz A. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS. 2012; 35 (10) 923Epidemiology, characteristics, and outcome of infective endocarditis in italy: the Italian Study on Endocarditis. Leone S; Ravasio V;
Durante-Mangone E; Crapis M; Carosi G; Scotton PG; Barzaghi N; Falcone M; Chinello P; Pasticci MB; Grossi P; Utili R; Viale P;
Rizzi M; Suter F. INFECTION. 2012; 31 (5) 739Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy. S. Baroncelli
;CM.Galluzzo;LE.Weimer; MF.Pirillo; A.Volpe; A.Mercuri; A.Cavalli; V.Fragola;L. Monno; A.Degli Antoni; N.Ladisa; D.Francisci;
R.Bucciardini; M.Floridia.. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2012; 67 (6) 1479Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010.. Colafigli M;Torti C;Trecarichi
EM;Albini L;Rosi A;Micheli V;Manca N;Penco G;Bruzzone B;Punzi G;Corsi P;Parruti G;Bagnarelli P;Monno L;Gonnelli A;Cauda
R;Di Giambenedetto S;ARCA UCSC and Brescia HIV resistance study groups; Francisci D. CLINICAL MICROBIOLOGY AND
INFECTION. 2012; 18 (8) E299Exposure to Abacavir and Biomarkers of Cardiovascular Disease in HIV-1-Infected Patients on Suppressive Antiretroviral Therapy: A
Longitudinal Study.. De Luca A;de Gaetano Donati K;Cozzi-Lepri A;Colafigli M;De Curtis A;Capobianchi MR;Antinori A;Giacometti
A;Magnani G;Vullo V;Cauda R;Iacoviello L;Monforte AD;and The ICoNA Foundation Study Group; Baldelli F. JOURNAL OF
ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2012; 60 (3) E98Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis..
Sterrantino G;Zaccarelli M;Colao G;Baldanti F;Di Giambenedetto S;Carli T;Maggiolo F;Zazzi M;For the ARCA Database Study
Group; Francisci D. INFECTION. 2012; 40 () 311Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition. B. Renga;A.
Mencarelli;C. D'Amore;S. Cipriani;F. Baldelli;A. Zampella;E. Distrutti;S. Fiorucci. FASEB JOURNAL. 2012; 26 () 3021Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort
characteristics.. May MT;Hogg RS;Justice AC;Shepherd BE;Costagliola D;Ledergerber B;Thiébaut R;Gill MJ;Kirk O;van Sighem
A;Saag MS;Navarro G;Sobrino-Vegas P;Lampe F;Ingle S;Guest JL;Crane HM;D'Arminio Monforte A;Vehreschild JJ;Sterne
JA;Antiretroviral Therapy Cohort Collaboration (ART-CC); Baldelli F. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2012;
41 (6) 1807HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes. Renga
B.; Francisci D.; D'Amore C.; Schiaroli E.; Carino A.; Baldelli F.; Fiorucci S.. BMC INFECTIOUS DISEASES. 2012; 12 () 274Human Immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral
therapy.
M.Franzetti;
M.Violin;G.Casazza;G.Meini;
a.Callegaro;P.Corsi;F.Maggiolo;AR.Pignataro;S.Paolucci;N.Giannotti;
D.Francisci;.Rossotti;G.Filice;T.Carli;M.Zazzi;C.Balotta.. CLINICAL MICROBIOLOGY AND INFECTION. 2012; 18 (3) E66In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from
Italian patients with infective endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin.. Farina C,
Russello G, Chinello P, Pasticci MB, Raglio A, Ravasio V, Rizzi M, Scarparo C, Vailati F, Suter F; Italian Infective Endocarditis
Study Group (SEI).. CHEMOTHERAPY. 2012; 57 (5) 426Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011..
Antinori A;Marcotullio S;Ammassari A;Andreoni M;Angarano G;Armignacco O;Carosi G;Cinque P;d'Arminio Monforte A;Di Perri
G;Ensoli B;Floridia M;Galli M;Mastroianni C;Matteelli A;Mazzotta F;Moroni M;Pal G;Puoti M;Puro V;Rizzardini G;Sagnelli E;Vella
S;Vullo V;Lazzarin A;Italian HIV Guidelines Working Group; Baldelli F. NEW MICROBIOLOGICA. 2012; 35 (2) 1134
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
Lingual tubercolosis: a rare disease in western countries. Pasticci MB; Floridi P; Schiaroli E; Stagni GM; De Socio GV; Longari F;
Baldelli F.. NEW MICROBIOLOGICA. 2012; 35 (2) 233Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D)
study.. Petoumenos K;Worm SW;Fontas E;Weber R;De Wit S;Bruyand M;Reiss P;El-Sadr W;Monforte AD;Friis-Møller N;Lundgren
JD;Law MG;D:A:D Study Group; Baldelli F. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2012; 15 articolo 17426 () Prevalence of prolonged amenorrhea in HIV-infected women:results from the Italian DIDI study.. Cicconi P; Ammassari A; Ladisa N;
Di Sora F; Bini t; Pierro P; D'ettorre G; Cattelan AM; Vichi F; Monforte AD; Francisci D; DIDI study. JOURNAL OF ACQUIRED
IMMUNE DEFICIENCY SYNDROMES. 2012; 61 (2) 19Reactivation of hepatitis B virus replication due to cytotoxic therapy:a five-year prospective study. Francisci D; Falcinelli F; Schiaroli
E; Capponi M; Belfiori B; Cecchini E; Baldelli F.. TUMORI. 2012; 98 (2) 220Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent
manner.. Mencarelli A; Francisci D; Renga B; D'Amore C; Cipriani S; Basile F; Schiaroli E; Baldelli F; Fiorucci S.. ANTIVIRAL
THERAPY. 2012; 17 (4) 669Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with
antiretroviral therapy.. Bibas M;Trotta MP;Cozzi-Lepri A;Lorenzini P;Pinnetti C;Rizzardini G;Angarano G;Caramello P;Sighinolfi
L;Mastroianni CM;Mazzarello G;Di Caro A;Di Giacomo C;d'Arminio Monforte A;Antinori A;ICONA Foundation Study Group;
Baldelli F. AMERICAN JOURNAL OF HEMATOLOGY. 2012; 87 (8) 749The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in
Monocytes. Renga B; .Francisci D;D'Amore C;Schiaroli E;Mencarelli A; S.Cipriani S;Baldelli F;Fiorucci S.. PLOS ONE. 2012; 7 (4)
e94798Trends and challenges in tuberculosis in a medium-sized southern European setting. M. B. Pasticci; R. Mazzolla; A. Mercuri; G.
Gamboni; J. C. Bombaci; C. Tiecco; M. Rubeca; R. Papili; F. Pasticci; L. Casali; G. Ferrara; F. Baldelli. INTERNATIONAL
JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2012; 16 (5) 645Tuberculosis After Gastrectomy, Plasmatic Concentration of Antitubercular Drugs. De Socio Giuseppe Vittorio; D’Avolio Antonio;
Sgrelli Alessio; Baietto Lorena; Lisa Malincarne; Di Perri Giovanni;Baldelli Franco. MEDITERRANEAN JOURNAL OF
HEMATOLOGY AND INFECTIOUS DISEASES. 2012; () Use of specific antiretroviral regimens among HIV-infected women in Italy at time of conception:2001-2011.. Floridia M, Ravizza M,
Guaraldi G, Pinnetti C, Marinelli P, Tamburrini E; Italian group on Surveillance on Antiretroviral Treatment in pregnancy, Francisci
D.. AIDS PATIENT CARE AND STDS. 2012; 26 (8) 439Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline
factors.. Bucciardini R;D'Ettorre G;Baroncelli S;Ceccarelli G;Parruti G;Weimer LE;Fragola V;Galluzzo CM;Pirillo MF;Lucattini
S;Bellagamba R;Francisci D;Ladisa N;Antoni AD;Guaraldi G;Manconi PE;Vullo V;Preziosi R;Cirioni O;Verucchi G;Floridia M;for
the ISS-NIA study group; Baldelli F. INTERNATIONAL JOURNAL OF STD & AIDS. 2012; 23 (7) 459[Loa loa filariasis in Italy: review of the literature with a clinical report]. Sgrelli A.; De Socio G.V.; Papili R.; D'Annibale M.L.;
Baldelli F.. LE INFEZIONI IN MEDICINA. 2011; 19 (3) 147A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis.. Ruhwald M.,
Dominguez J., Latorre I., Losi M., Richeldi L., Pasticci M.B., Mazzolla R., Goletti D., Butera O., Bruchfeld J., Gaines H., Gerogianni
I., Tuuminen T., Ferrara G., Eugen-Olsen J., Ravn P.; TBNET. TUBERCULOSIS. 2011; 91 (3) 260A novel methodology for large-scale phylogeny partition. Prosperi MC, Ciccozzi M, Fanti I, Saladini f, pecorari m, Borghi V, Di
Giambenedetto S, Bruzzone b, Capetti A, Vivarelli A, Rusconi S, Re MC, Gismondo MR, Sighinolfi l, Gray RR, Salemi M, Zazzi M,
De Luca A; ARCA Collaborative group, Francisci D.. NATURE COMMUNICATIONS. 2011; 2 (321) A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral
therapy regimen. Prosperi MC, Di Giambenedetto S, Fanti I, Meini G, Bruzzone B, Callegaro A, Penco G, Bagnarelli P, Micheli V,
Paolini E, Di Biagio A, Ghisetti V, Di Pietro M, Zazzi M, De Luca A; ARCA cohort, Francisci D.. BMC MEDICAL INFORMATICS
AND DECISION MAKING. 2011; 11 () 40Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a
relationship between tolerance and outcome.. Maria Bruna Pasticci;Amedeo Moretti;Giuliano Stagni;Veronica Ravasio;Laura
Soavi;Annibale Raglio;Francesca Vailati;Angela Cardaccia;Antonella Santucci;Rita Papili;Alessio Sgrelli;Carlo Pallotto;Franco
Baldelli. ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS. 2011; 10 (26) Detection of drug resistance mutations at low plasma HIV-1-RNA load in a European multicentre cohort study. Prosperi MC, Mackie
n, Di Giambenedetto S, Zazzi M, Camacho r, fanti I, Torti C, Sonnerborg A, Kaiser R, Codoner FM, Van Laethem K, Bansi L, van de
Vijver DA, Geretti AM, De luca A; SEHERE consortium, Francisci D.. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY.
2011; 66 (8) 1886Diagnosing tuberculosis in pregnancy: a case report.. Pasticci M.B.; Lupi C.; Mazzolla R.; Bragetti P.; Rubeca M.; Sfara C.; Baldoni
A.; Fratini D.; Baldelli F.. NEW MICROBIOLOGICA. 2011; 34/2011 (3) 327Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA. Fiorucci S; Cipriani S;
Mencarelli A; Baldelli F; Bifulco G; Zampella A.. MINI-REVIEWS IN MEDICINAL CHEMISTRY. 2011; 11 (9) 753Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008..
Prosperi MC;Cozzi-Lepri A;Antinori A;Cassola G;Torti C;Ursitti MA;Pellizzer GP;Giacometti A;d'Arminio Monforte A;De Luca
A;Icona Foundation Study Group; Baldelli F. HIV MEDICINE. 2011; 12 (3) 174Glucose
plasma
levels
and
pregnancy
outcomes
in
women
with
HIV.
A.Meloni;M.Floridia;S.Alberico;E.Tamburrini;C.pinnetti;A.Bucceri;G.Masuelli;A.Viganò;G.Liuzzi;
AD.Antoni;
G.Guaraldi;A.Spinillo;R.Marocco; S.Dalzero;D.Francisci;M.Ravizza. HIV CLINICAL TRIALS. 2011; 12 (6) 299HIV-2 infection, end-stage renal disease and protease inhibitor intolerance, which salvage regimen?. Francisci D; Martinelli L; Weimer
LE; Zazzi M; Floridia m; Masini G; Baldelli F. CLINICAL DRUG INVESTIGATION. 2011; 31 (5) 345Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction.. Francisci D.; Falcinelli E.; Belfiori B.; Petito E.; Fierro
T.; Baldelli F.; Gresele P.. AIDS PATIENT CARE AND STDS. 2011; 25/2011 (10) 567Inhibition of NF-κB by a PXR-dependent pathwaymediates counter-regulatory activities of rifaximin on innate immunity inintestinal
epithelial cells.. Mencarelli A; Renga B; Palladino G; Claudio D; Ricci P; Distrutti E; Barbanti
M; Baldelli F; Fiorucci S.. EUROPEAN JOURNAL OF PHARMACOLOGY. 2011; 668 (1-2) 3175
109. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons.. Antinori
A;Marcotullio S;Ammassari A;Andreoni M;Angarano G;Carosi G;Cinque P;d'Arminio Monforte A;Di Perri G;Ensoli B;Ferrazzi
E;Galli M;Mastroianni C;Matteelli A;Mazzotta F;Moroni M;Palù G;Puoti M;Puro V;Rizzardini G;Sagnelli E;Suter F;Vella S;Lazzarin
A;Italian HIV Guidelines Working Group; Baldelli F. NEW MICROBIOLOGICA. 2011; 34 (2) 113110. Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors
(NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI.. Torti C;d'Arminio-Monforte A;Pozniak
AL;Lapadula G;Cologni G;Antinori A;De Luca A;Mussini C;Castagna A;Cicconi P;Minoli L;Costantini A;Carosi G;Liang H;Cesana
BM;MASTER Chelsea & Westminster ICONA Modena and S. Raffaele HIV Cohortsm; Baldelli F. BMC INFECTIOUS
DISEASES. 2011; 11 articolo 23 () 111. Malignant syphilis with ocular involvement in an HIV-infected patient. De Socio GV; Simonetti S; Tomasini C; Ansidei V; Pasticci
MB; Baldelli F. INTERNATIONAL JOURNAL OF STD & AIDS. 2011; 22 (5) 298112. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count..
Marchetti G;Cozzi-Lepri A;Merlini E;Bellistrì GM;Castagna A;Galli M;Verucchi G;Antinori A;Costantini A;Giacometti A;di Caro
A;D'arminio Monforte A;ICONA Foundation Study Group; Baldelli F. AIDS. 2011; 25 (11) 1385113. Monolateral visual loss due to cryptococcal meningitis.. De Socio GV;Bernini L;Menduno P;Pitzurra L;Leone F;Baldelli F. JOURNAL
OF THE INTERNATIONAL ASSOCIATION OF PHYSICIANS IN AIDS CARE. 2011; 10 () 76114. No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failingantiretroviral
therapy.. Gianotti N, Galli L, Zazzi M, Ghisetti V, Bonora S, Francisci D, Micheli V, Meraviglia P, Corsi P, Bruzzone B, Menzo S, Di
Giambenedetto S, De Luca A, Filice G, Penco G, Castagna A; ARCA database initiative.. JOURNAL OF MEDICAL VIROLOGY.
2011; 83 (3) 391115. Pregnancy Outcomes in Women with Advanced HIV Infection in Italy.. Baroncelli S; Tamburrini E; Ravizza M; Pinnetti C; Dalzero S;
Scatà M; Crepaldi A; Liuzzi G; Molinari A; Vimercati A; Maccabruni A; Francisci D; Rubino E; Floridia M. AIDS PATIENT CARE
AND STDS. 2011; 25 (11) 639116. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients
enrolled in a large Italian cohort.. Vescini F.; Cozzi-Lepri A.; Borderi M.; Re M.C.; Maggiolo F.; De Luca A.; Cassola G.; Vullo V.;
Carosi G.; Antinori A.; Tozzi V.; Monforte A.D.; Baldelli F.; Francisci D.; Icona Foundation Study Group.. JOURNAL OF
ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2011; 58/2011 (2) 163117. rubella sesceptibility profile in pregnant women with HIV. Floridia m, Pinnetti C, Ravizza M, Tibaldi c, Sansone M, Fiscon M,
Guaraldi G, Guerra b, Alberico S, Spinillo A, Castelli P, Dalzero S, Cavaliere AF, Tamburrini E;Italian Group on Surveillance on
Antiretroviral
Treatment
in
Pregnancy,
Francisci D.. CLINICAL INFECTIOUS DISEASES. 2011; 52 (7) 960118. Severe acute hepatitis B treated with entecavir.. De Socio GV;Sgrelli A;Tosti A;Baldelli F. MEDITERRANEAN JOURNAL OF
HEMATOLOGY AND INFECTIOUS DISEASES. 2011; 3 (1) e2011010119. The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis..
Cipriani S; Mencarelli A; Chini MG; Distrutti E; Renga B; Bifulco G; Baldelli F; Donini A; Fiorucci S. PLOS ONE. 2011; 6 (10)
e25637120. Tuberculosis and HIV co-infection: do we have a surveillance system in Europe?. Pontali E.; Pasticci M.B.; Matteelli A; Baldelli F;
Migliori GB.. EUROPEAN RESPIRATORY JOURNAL. 2011; 38 (6) 1258-
6